Nov 2017: Diagnosed with Stage IV high-risk Neuroblastoma.
Nov 2017–Apr 2019: Completed standard treatment; NED.
Apr 2019–Apr 2021: Completed DFMO clinical trial.
Apr 2022: Relapse.
Apr 2022–Jun 2023: Completed relapse treatment; NED again.
Jun 2023–Jun 2024: High-dose DFMO (compassionate use) clinical trial.
Jun 2024: Second relapse.
Jul 2025: NED again.
Mar 2026: Relapse.
Tuesday, March 6, 2018
Happy Birthday, Andrew!
Happy 10th Birthday, Andrew!
We're so proud of how you're handling your sister's diagnosis; she's so lucky to have such a protective and sweet brother!
Unconditional love forever and ever,
Mommy and Daddy
Happy Birthday Andrew. ��
ReplyDelete